ATE354376T1 - Zusammensetzungen für die elektroporation - Google Patents

Zusammensetzungen für die elektroporation

Info

Publication number
ATE354376T1
ATE354376T1 AT00915386T AT00915386T ATE354376T1 AT E354376 T1 ATE354376 T1 AT E354376T1 AT 00915386 T AT00915386 T AT 00915386T AT 00915386 T AT00915386 T AT 00915386T AT E354376 T1 ATE354376 T1 AT E354376T1
Authority
AT
Austria
Prior art keywords
electroporation
compositions
drugs
percutaneous absorbability
elevating
Prior art date
Application number
AT00915386T
Other languages
English (en)
Inventor
Yoshihiro Tokudome
Koji Owaku
Kenichi Goto
Kenji Sugibayashi
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Application granted granted Critical
Publication of ATE354376T1 publication Critical patent/ATE354376T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00915386T 1999-10-14 2000-04-06 Zusammensetzungen für die elektroporation ATE354376T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29172199 1999-10-14

Publications (1)

Publication Number Publication Date
ATE354376T1 true ATE354376T1 (de) 2007-03-15

Family

ID=17772544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915386T ATE354376T1 (de) 1999-10-14 2000-04-06 Zusammensetzungen für die elektroporation

Country Status (8)

Country Link
US (1) US7089053B1 (de)
EP (1) EP1222932B1 (de)
JP (1) JP4868679B2 (de)
AT (1) ATE354376T1 (de)
AU (1) AU3671900A (de)
CA (1) CA2387953C (de)
DE (1) DE60033542T2 (de)
WO (1) WO2001026689A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE328581T1 (de) * 1999-10-15 2006-06-15 Pola Chem Ind Inc Perkutane absorptionsbeschleuniger für die elektroporation
US8813221B1 (en) 2008-09-25 2014-08-19 Sonicwall, Inc. Reassembly-free deep packet inspection on multi-core hardware

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933184A (en) 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
JPH02468A (ja) * 1987-07-14 1990-01-05 Nisshin Flour Milling Co Ltd 乳酸桿菌に外来ｄｎａを導入する方法
WO1989006555A1 (en) 1988-01-21 1989-07-27 Massachusetts Institute Of Technology Transport of molecules across tissue using electroporation
US5069908A (en) * 1989-06-19 1991-12-03 Henley International, Inc. Crosslinked hydrogel and method for making same
GB8921710D0 (en) * 1989-09-26 1989-11-08 Mentholatum Co Ltd Ibuprofen triturates and topical compositions containing same
ATE143603T1 (de) 1990-03-30 1996-10-15 Yasunori Morimoto Transdermal absorbierbares mittel mit morphin hydrochlorid
US5176918A (en) * 1990-12-20 1993-01-05 Jones Jeffry L Topical medicament
JPH0616538A (ja) 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
US5997501A (en) 1993-11-18 1999-12-07 Elan Corporation, Plc Intradermal drug delivery device
JPH10511008A (ja) * 1994-06-24 1998-10-27 シグナス， インコーポレイテッド 膜透過性制御のための電子電圧パルスを用いた生物学的活性因子のパルス使用送達システム
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US5990179A (en) 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
DE69630918T2 (de) 1995-06-09 2004-10-28 Hisamitsu Pharmaceutical Co., Inc., Tosu Matrix für Iontophorese
DE69629628T2 (de) 1995-06-14 2004-06-17 Hisamitsu Pharmaceutical Co., Inc., Tosu Schnittstelle für Iontophorese
JP3898250B2 (ja) * 1996-03-26 2007-03-28 久光製薬株式会社 エレクトロポレーション用マイクロエマルション製剤
WO1998029134A2 (en) * 1996-12-31 1998-07-09 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
CA2330211A1 (en) * 1998-06-08 1999-12-16 Karel Petrak Formulations for electroporation
WO1999065563A1 (en) * 1998-06-19 1999-12-23 Genetronics, Inc. Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction
HUP0103606A3 (en) 1998-10-16 2002-05-28 Novo Nordisk As Insulin preparations for pulmonary delivery containing menthol
US6678558B1 (en) * 1999-03-25 2004-01-13 Genetronics, Inc. Method and apparatus for reducing electroporation-mediated muscle reaction and pain response

Also Published As

Publication number Publication date
EP1222932A4 (de) 2004-05-12
EP1222932A1 (de) 2002-07-17
AU3671900A (en) 2001-04-23
JP4868679B2 (ja) 2012-02-01
US7089053B1 (en) 2006-08-08
CA2387953C (en) 2008-12-09
DE60033542D1 (de) 2007-04-05
WO2001026689A1 (fr) 2001-04-19
EP1222932B1 (de) 2007-02-21
CA2387953A1 (en) 2001-04-19
DE60033542T2 (de) 2007-11-22

Similar Documents

Publication Publication Date Title
BG106440A (en) Nitrogen-heterocyclic derivatives as nos inhibitors
DK1613304T3 (da) DPP-IV-inhibitorer
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
ATE492526T1 (de) Retinoid derivate mit antiangiogener, antitumor und proapoptotischer wirkung
ATE344055T1 (de) Zusammensetzungen für die elektroporation
MXPA02011370A (es) Iminoazinas substituidas.
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
UY26133A1 (es) Derivado sustituido de pirazol.
WO2005009345A3 (en) 2-desmethyl ansamycin compounds
SI1831239T1 (sl) Postopek za pripravo gamma laktona hidroksi beta beta beta beta bismetilen alfa pregn en on karboksilne kisline in ključniintermediati za ta postopek
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
ATE354376T1 (de) Zusammensetzungen für die elektroporation
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol
DE59910585D1 (en) 3,4-dihydrochinolin-derivative als stickstoffmonoxid-synthase (nos) inhibitoren
GT200200250A (es) Compuestos hexaciclicos
ATE206125T1 (de) Furoindolizine
NO20053208D0 (no) Metode for reduktiv dehalogenering.
ATE328581T1 (de) Perkutane absorptionsbeschleuniger für die elektroporation
SG145573A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
HN1999000157A (es) 1,2,3 tetrahidroquinolinas 2 - sustituidas 4 - amino sustituidas.
CY1110529T1 (el) Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties